A detailed history of Invesco Ltd. transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 114,156 shares of RLAY stock, worth $553,656. This represents 0.0% of its overall portfolio holdings.

Number of Shares
114,156
Previous 114,513 0.31%
Holding current value
$553,656
Previous $746,000 8.31%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$6.23 - $9.51 $2,224 - $3,395
-357 Reduced 0.31%
114,156 $808,000
Q2 2024

Aug 13, 2024

SELL
$5.9 - $8.02 $13,983 - $19,007
-2,370 Reduced 2.03%
114,513 $746,000
Q1 2024

May 14, 2024

SELL
$7.5 - $12.07 $226,485 - $364,489
-30,198 Reduced 20.53%
116,883 $970,000
Q4 2023

Feb 12, 2024

SELL
$6.01 - $11.48 $37,424 - $71,485
-6,227 Reduced 4.06%
147,081 $1.62 Million
Q3 2023

Nov 13, 2023

BUY
$8.24 - $12.97 $217,733 - $342,719
26,424 Added 20.83%
153,308 $1.29 Million
Q2 2023

Aug 11, 2023

BUY
$9.99 - $18.27 $528,780 - $967,049
52,931 Added 71.57%
126,884 $1.59 Million
Q1 2023

May 12, 2023

BUY
$15.0 - $22.76 $226,275 - $343,334
15,085 Added 25.63%
73,953 $1.22 Million
Q4 2022

Feb 13, 2023

BUY
$14.16 - $24.02 $15,023 - $25,485
1,061 Added 1.84%
58,868 $879,000
Q3 2022

Nov 14, 2022

BUY
$18.07 - $31.37 $3,397 - $5,897
188 Added 0.33%
57,807 $1.29 Million
Q2 2022

Aug 15, 2022

BUY
$13.31 - $34.88 $57,139 - $149,739
4,293 Added 8.05%
57,619 $966,000
Q1 2022

May 16, 2022

BUY
$20.26 - $32.36 $475,927 - $760,168
23,491 Added 78.74%
53,326 $1.6 Million
Q4 2021

Feb 14, 2022

BUY
$26.0 - $37.03 $63,440 - $90,353
2,440 Added 8.91%
29,835 $917,000
Q3 2021

Nov 15, 2021

BUY
$29.75 - $37.99 $122,510 - $156,442
4,118 Added 17.69%
27,395 $864,000
Q2 2021

Aug 17, 2021

BUY
$27.5 - $38.19 $377,437 - $524,157
13,725 Added 143.69%
23,277 $852,000
Q1 2021

May 17, 2021

BUY
$32.52 - $61.53 $82,860 - $156,778
2,548 Added 36.38%
9,552 $330,000
Q4 2020

Feb 16, 2021

BUY
$35.51 - $54.03 $248,712 - $378,426
7,004 New
7,004 $291,000

Others Institutions Holding RLAY

About Relay Therapeutics, Inc.


  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $583M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.